Innovative Australian scientist Dr Ali Zaid has joined Griffith University’s Institute for Glycomics to lead a project on Ross River...
Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Academic offers insights into mosquito-borne diseases for live Q&A symposium.
Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.
By Suresh Mahalingam, Principal Research Leader, Institute for Glycomics As Zika fear rises, especially in the wake of the World...
